BSE Live
Nov 19, 16:01Prev. Close
45.74
Open Price
45.75
Bid Price (Qty.)
45.52 (1)
Offer Price (Qty.)
45.75 (40)
NSE Live
Nov 19, 15:59Prev. Close
45.71
Open Price
45.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
45.48 (331)
| Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.72 | 0.64 | 0.58 | 0.52 | 0.35 | |
| Diluted EPS (Rs.) | 0.72 | 0.64 | 0.58 | 0.52 | 0.35 | |
| Cash EPS (Rs.) | 1.48 | 1.48 | 1.32 | 1.26 | 1.13 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 6.83 | 6.17 | 5.57 | 4.99 | 4.65 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 6.83 | 6.17 | 5.57 | 4.99 | 4.65 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 17.61 | 15.95 | 12.47 | 12.17 | 10.06 | |
| PBDIT/Share (Rs.) | 1.64 | 1.53 | 1.42 | 1.43 | 1.45 | |
| PBIT/Share (Rs.) | 0.88 | 0.68 | 0.68 | 0.68 | 0.68 | |
| PBT/Share (Rs.) | 0.83 | 0.64 | 0.58 | 0.52 | 0.45 | |
| Net Profit/Share (Rs.) | 0.72 | 0.64 | 0.58 | 0.52 | 0.35 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 9.32 | 9.57 | 11.37 | 11.72 | 14.44 | |
| PBIT Margin (%) | 4.98 | 4.27 | 5.42 | 5.59 | 6.73 | |
| PBT Margin (%) | 4.73 | 3.98 | 4.65 | 4.23 | 4.42 | |
| Net Profit Margin (%) | 4.08 | 3.98 | 4.65 | 4.23 | 3.48 | |
| Return on Networth / Equity (%) | 10.52 | 10.31 | 10.42 | 10.32 | 7.54 | |
| Return on Capital Employed (%) | 11.86 | 10.27 | 11.32 | 12.78 | 4.10 | |
| Return on Assets (%) | 4.88 | 4.61 | 4.42 | 4.22 | 2.94 | |
| Total Debt/Equity (X) | 0.04 | 0.04 | 0.49 | 0.54 | 0.20 | |
| Asset Turnover Ratio (%) | 119.63 | 115.79 | 0.99 | 1.01 | 84.59 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.06 | 0.88 | 0.72 | 0.58 | 0.97 | |
| Quick Ratio (X) | 0.66 | 0.60 | 0.49 | 0.38 | 0.70 | |
| Inventory Turnover Ratio (X) | 5.98 | 7.90 | 3.23 | 4.37 | 11.08 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 403.35 | 754.70 | 1,504.26 | 968.45 | 1,332.72 | |
| EV/Net Operating Revenue (X) | 0.51 | 1.05 | 2.68 | 1.77 | 2.95 | |
| EV/EBITDA (X) | 5.46 | 10.99 | 23.57 | 15.08 | 20.39 | |
| MarketCap/Net Operating Revenue (X) | 0.54 | 1.08 | 2.47 | 1.56 | 2.59 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.40 | 2.80 | 5.54 | 3.81 | 5.61 | |
| Price/Net Operating Revenue | 0.54 | 1.08 | 2.47 | 1.56 | 2.59 | |
| Earnings Yield | 0.08 | 0.04 | 0.02 | 0.03 | 0.01 |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y